Education
About Us
Working with TipRanks
Follow Us
Perrigo Company (PRGO)
:PRGO
PRGO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$20.52 - $30.93
Previous CloseN/A
Volume301.70K
Average Volume (3M)1.64M
Market Cap
$2.86B
Enterprise Value$7.05B
Total Cash (Recent Filing)$454.20M
Total Debt (Recent Filing)$3.83B
Price to Earnings (P/E)―
Beta0.27
Next Earnings
Nov 05, 2025EPS Estimate
0.76Last Dividend Ex-Date
Aug 29, 2025Dividend Yield5.36%
Share Statistics
EPS (TTM)0.57
Shares Outstanding137,582,810
10 Day Avg. Volume1,903,797
30 Day Avg. Volume1,638,366
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap2.46
Enterprise Value/Revenue1.63
Enterprise Value/Gross Profit4.56
Enterprise Value/Ebitda11.53
Forecast
1Y Price Target
$28.50Price Target Upside35.01% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Consumer BehaviorPerrigo is expected to benefit from consumers trading down in frequently used categories like soaps, shampoos, and analgesics.
Guidance And StrategyPRGO reiterated their FY25 guidance, which is seen as positive given the fast-changing macro environment.
Operational ImprovementsProject Energize and the Supply Chain Reinvention Program continue to help drive operational and cost improvements.
Bears Say
Infant Formula BusinessRecent wins have been overshadowed by a slower than expected recovery in the infant formula business.
Revenue ImpactThe sale of the dermacosmetics business, which had significant sales and operating income, could impact Perrigo's revenue streams.
Sales PerformanceSales were down -0.9% YOY, lower than the analyst's estimate, impacted by divestitures and exited products.
Perrigo Company News
PRGO FAQ
What was Perrigo Company’s price range in the past 12 months?
Perrigo Company lowest stock price was $20.52 and its highest was $30.93 in the past 12 months.
What is Perrigo Company’s market cap?
Perrigo Company’s market cap is $2.86B.
When is Perrigo Company’s upcoming earnings report date?
Perrigo Company’s upcoming earnings report date is Nov 05, 2025 which is in 40 days.
How were Perrigo Company’s earnings last quarter?
Perrigo Company released its earnings results on Aug 06, 2025. The company reported $0.57 earnings per share for the quarter, missing the consensus estimate of $0.595 by -$0.025.
Is Perrigo Company overvalued?
According to Wall Street analysts Perrigo Company’s price is currently Undervalued.
Does Perrigo Company pay dividends?
Perrigo Company pays a Quarterly dividend of $0.29 which represents an annual dividend yield of 5.36%. See more information on Perrigo Company dividends here
What is Perrigo Company’s EPS estimate?
Perrigo Company’s EPS estimate is 0.76.
How many shares outstanding does Perrigo Company have?
Perrigo Company has 137,582,810 shares outstanding.
What happened to Perrigo Company’s price movement after its last earnings report?
Perrigo Company reported an EPS of $0.57 in its last earnings report, missing expectations of $0.595. Following the earnings report the stock price went down -11.331%.
Which hedge fund is a major shareholder of Perrigo Company?
Currently, no hedge funds are holding shares in PRGO
Perrigo Company Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$28.50 (35.01% Upside)
$28.50 (35.01% Upside)
Blogger Sentiment
Bullish
PRGO Sentiment 70%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 77.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $355.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.2%
Last 30 Days ▼ 4.4%
Last 30 Days ▼ 4.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-15.87%
12-Months-Change
Fundamentals
Return on Equity
-1.32%
Trailing 12-Months
Asset Growth
-2.92%
Trailing 12-Months
Company Description
Perrigo Company
Perrigo Company plc is a global healthcare supplier that focuses on providing quality, affordable self-care products. Founded in 1887 and headquartered in Dublin, Ireland, Perrigo operates primarily in the over-the-counter (OTC) pharmaceutical and consumer healthcare sectors. The company specializes in developing, manufacturing, and distributing a broad range of products including non-prescription medications, vitamins, dietary supplements, and personal care items. Its mission is to empower consumers to take charge of their health by providing them with affordable, accessible healthcare solutions.
PRGO Company Deck
PRGO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive developments and challenges. Significant achievements include growth in the infant formula and OTC brand sectors, successful cost-saving initiatives, and improved EPS. However, these were tempered by declines in gross margin, challenges in the infant formula market, and soft seasonal trends impacting sales. Despite these challenges, the company's strategic initiatives seem to be gaining traction, suggesting a cautiously optimistic outlook.View all PRGO earnings summariesPRGO Stock 12 Month Forecast
Average Price Target
$28.50
▲(35.01% Upside)
Technical Analysis
Viatris
―
Supernus Pharmaceuticals
―
Teva Pharmaceutical
―
Indivior
―
Amneal Pharmaceuticals
―
Ownership Overview
0.33% Insiders
32.34% Mutual Funds
32.21% Other Institutional Investors
7.34% Public Companies and
Individual Investors